Potential Molecular Target Prediction and Docking Verification of Hua-Feng-Dan in Stroke Based on Network Pharmacology

Abstract EN

Objective.

Hua-Feng-Dan (HFD) is a Chinese medicine for stroke.

This study is to predict and verify potential molecular targets and pathways of HFD against stroke using network pharmacology.

Methods.

The TCMSP database and TCMID were used to search for the active ingredients of HFD, and GeneCards and DrugBank databases were used to search for stroke-related target genes to construct the “component-target-disease” by Cytoscape 3.7.1, which was further filtered by MCODE to build a core network.

The STRING database was used to obtain interrelationships by topology and to construct a protein-protein interaction network.

GO and KEGG were carried out through DAVID Bioinformatics.

Autodock 4.2 was used for molecular docking.

BaseSpace was used to correlate target genes with the GEO database.

Results.

Based on OB ≥ 30% and DL ≥ 0.18, 42 active ingredients were extracted from HFD, and 107 associated targets were obtained.

PPI network and Cytoscape analysis identified 22 key targets.

GO analysis suggested 51 cellular biological processes, and KEGG suggested that 60 pathways were related to the antistroke mechanism of HFD, with p53, PI3K-Akt, and apoptosis signaling pathways being most important for HFD effects.

Molecular docking verified interactions between the core target (CASP8, CASP9, MDM2, CYCS, RELA, and CCND1) and the active ingredients (beta-sitosterol, luteolin, baicalein, and wogonin).

The identified gene targets were highly correlated with the GEO biosets, and the stroke-protection effects of Xuesaitong in the database were verified by identified targets.

Conclusion.

HFD could regulate the symptoms of stroke through signaling pathways with core targets.

This work provided a bioinformatic method to clarify the antistroke mechanism of HFD, and the identified core targets could be valuable to evaluate the antistroke effects of traditional Chinese medicines.